Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic CardiomyopathiesMartín Ortiz-Genga, Lorenzo Monserrat, Julián Palomino et al.|Journal of the American College of Cardiology|2016Cited by 472
Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving mythsEsther González-López, Pablo García‐Pavía, Christian Gagliardi et al.|European Heart Journal|2017Cited by 373
Genetic Variants Associated With Cancer Therapy–Induced CardiomyopathyPablo García‐Pavía, Bonnie Ky, Yuri Kim et al.|Circulation|2019Cited by 346
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac AmyloidosisMichele Boldrini, Marianna Fontana, Francesco Cappelli et al.|JACC. Cardiovascular imaging|2019Cited by 258
Association of Sleep Duration and Quality With Subclinical AtherosclerosisFernándo Domínguez, José M. Ordovás, Valentı́n Fuster et al.|Journal of the American College of Cardiology|2019Cited by 215